YEDA Research and Development Company LTD., the commercial
arm of the Weizmann Institute of Science, today announced it has entered into a
license agreement with Adobe Systems Incorporated related to a bidirectional
similarity measure to summarize visual data.
...
|
19/1/2012
|
|
Presentations by:
Dr. Sabine Albrecht
Eurice GmbH Saarbrücken (Germany)
&
Veronica Munoz and Gary Serbin
Hogan Lovells US LLP...
|
25/12/2011
|
|
|
23/10/2011
|
|
|
4/8/2011
|
|
Greenearth Energy Limited (ASX:GER) is pleased to announce that it has successfully concluded
negotiations with Yeda Research and Development Co. Ltd., the commercial arm of Israel’s Weizmann
Institute of Science, for an exclusive, worldwide Research and Licence Agreement, which it will assign to an
ultimate subsidiary company NEWCO2FUELS LTD (NewCo2Fuels), for a revolutionary technology that has
the ability to convert CO2 emissions into fuel....
|
30/6/2011
|
ישראל מדורגת במקום מצויין בכל הקשור למספר הפרויקטים המבשילים לכדי חברות סטארט אפ שמקורם באוניברסיטאות, מכוני מחקר ובתי חולים ...
|
3/6/2010
|
ד״ר רות בן יקר, מנהלת המחלקה לפיתוח עסקי של
״ידע״, חברת הייבום של מכון ויצמן למדע, חושפת
את דרכי הפעולה ותפיסת העולם של חברת המיסחור,
שליוותה את ההצלחות הגדולות של המכון, כמו
הקופקסון, ארביטוקס ורביף ...
|
3/6/2010
|
|
...
|
17/5/2010
|
Every licensing agreement is unique. Indeed, the deal has to take into account the needs and expectations of the two parties, the intellectual property rights, upfront, milestones and royalties payments. Then, according to the technology licensed and the typology of the licensor structure, what is the right strategy for licensing? This presentation reviews some of the current trends in licensing deals. ...
|
19/10/2009
|
Receiving back a technology that was already licensed-out is not one of the best things that can happen to a tech-transfer licensing officer. A returned technology immediately carries the status of rejection, regardless of whether or not it was tested for efficacy or toxicity. The industry people hurry to tag it as a failure, usually without making the effort to dive into the details of the history of its licensed days. ...
|
27/7/2009
|